The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer

U. Banerji, D.R. Camidge, H.M.W. Verheul, R. Agarwal, D. Sarker, S.B. Kaye, I.M.E. Desar, J.N.H. Timmer-Bonte, S.G. Eckhardt, K.D. Lewis, K.H. Brown, M.V. Cantarini, C. Morris, S.M.A. George, P.D. Smith, C.M.L. van Herpen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1613-1623
JournalClinical Cancer Research
Volume16
Issue number5
DOIs
Publication statusPublished - 2010

Cite this

Banerji, U. ; Camidge, D.R. ; Verheul, H.M.W. ; Agarwal, R. ; Sarker, D. ; Kaye, S.B. ; Desar, I.M.E. ; Timmer-Bonte, J.N.H. ; Eckhardt, S.G. ; Lewis, K.D. ; Brown, K.H. ; Cantarini, M.V. ; Morris, C. ; George, S.M.A. ; Smith, P.D. ; van Herpen, C.M.L. / The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer. In: Clinical Cancer Research. 2010 ; Vol. 16, No. 5. pp. 1613-1623.
@article{78be777db2d8429f8a37eafaa8a9c8bb,
title = "The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer",
author = "U. Banerji and D.R. Camidge and H.M.W. Verheul and R. Agarwal and D. Sarker and S.B. Kaye and I.M.E. Desar and J.N.H. Timmer-Bonte and S.G. Eckhardt and K.D. Lewis and K.H. Brown and M.V. Cantarini and C. Morris and S.M.A. George and P.D. Smith and {van Herpen}, C.M.L.",
year = "2010",
doi = "10.1158/1078-0432.CCR-09-2483",
language = "Undefined/Unknown",
volume = "16",
pages = "1613--1623",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

Banerji, U, Camidge, DR, Verheul, HMW, Agarwal, R, Sarker, D, Kaye, SB, Desar, IME, Timmer-Bonte, JNH, Eckhardt, SG, Lewis, KD, Brown, KH, Cantarini, MV, Morris, C, George, SMA, Smith, PD & van Herpen, CML 2010, 'The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer' Clinical Cancer Research, vol. 16, no. 5, pp. 1613-1623. https://doi.org/10.1158/1078-0432.CCR-09-2483

The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer. / Banerji, U.; Camidge, D.R.; Verheul, H.M.W.; Agarwal, R.; Sarker, D.; Kaye, S.B.; Desar, I.M.E.; Timmer-Bonte, J.N.H.; Eckhardt, S.G.; Lewis, K.D.; Brown, K.H.; Cantarini, M.V.; Morris, C.; George, S.M.A.; Smith, P.D.; van Herpen, C.M.L.

In: Clinical Cancer Research, Vol. 16, No. 5, 2010, p. 1613-1623.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer

AU - Banerji, U.

AU - Camidge, D.R.

AU - Verheul, H.M.W.

AU - Agarwal, R.

AU - Sarker, D.

AU - Kaye, S.B.

AU - Desar, I.M.E.

AU - Timmer-Bonte, J.N.H.

AU - Eckhardt, S.G.

AU - Lewis, K.D.

AU - Brown, K.H.

AU - Cantarini, M.V.

AU - Morris, C.

AU - George, S.M.A.

AU - Smith, P.D.

AU - van Herpen, C.M.L.

PY - 2010

Y1 - 2010

U2 - 10.1158/1078-0432.CCR-09-2483

DO - 10.1158/1078-0432.CCR-09-2483

M3 - Article

VL - 16

SP - 1613

EP - 1623

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 5

ER -